Aristeidis E Boukouris

4PUBLICATIONS
21CO-AUTHORS
Molecular targetsEpigenetics (incl. genome methylation and epigenomics)Cancer therapy (excl. chemotherapy and radiation therapy)Respiratory diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Aug 14, 2025
MicroRNA Expression Analysis and Biological Pathways in Chemoresistant Non-Small Cell Lung Cancer.

Chara Papadaki, Maria Mortoglou, Aristeidis E Boukouris

|Nov 01, 2021
SNPs for Genes Encoding the Mitochondrial Proteins Sirtuin3 and Uncoupling Protein 2 Are Associated With Disease Severity, Type 2 Diabetes, and Outcomes in Patients With Pulmonary Arterial Hypertension and This Is Recapitulated in a New Mouse Model Lacking Both Genes.

Yongneng Zhang, Sotirios D Zervopoulos, Aristeidis E Boukouris

|Feb 08, 2019
Tissue-specific regulation of p53 by PKM2 is redox dependent and provides a therapeutic target for anthracycline-induced cardiotoxicity.

Bruno Saleme, Vikram Gurtu, Yongneng Zhang

|Oct 27, 2017
Inhibition of pyruvate dehydrogenase kinase improves pulmonary arterial hypertension in genetically susceptible patients.

Evangelos D Michelakis, Vikram Gurtu, Linda Webster

Pageof 1

Frequent Collaborators

2 joint publications

Evangelos D Michelakis

2 joint publications

Gopinath Sutendra

1 joint publications

Geoffrey Watson

1 joint publications

Luke Howard